Analyst stock forecast
Apnimed Forecast: $50.50 Analyst Target
APMD has a $50.50 target, Strong Buy rating and 2 analysts. As of 2026-08-29.
Direct answer
Apnimed's average price target is $50.50.
The target implies +70% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +38%, the high target implies +102%, and the range spans 64% of the current price.
Forecast evidence checked August 29, 2026.
Get free Apnimed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $29.71
- Average price target
- $50.50
- High price target
- $60.00
- Low price target
- $41.00
- Low target gap
- +38%
- Target upside
- +70%
- High target gap
- +102%
- Target range width
- 64%
- Consensus rating
- Strong Buy
- Analysts
- 2
- Evidence date
- August 29, 2026
- Valid through
- September 5, 2026
Explore related company data
Read the frequently asked questions.
What is Apnimed's average price target?
Apnimed's verified average price target is $50.50. The target range is $41.00 to $60.00.
How far are Apnimed's low and high targets from the recorded price?
The low target implies +38%, while the high target implies +102%.
How many analysts are included in Apnimed's consensus?
The verified consensus includes 2 analysts.
How is Apnimed's target upside or downside calculated?
The average target of $50.50 is divided by the recorded price of $29.71, then one is subtracted to produce +70%. This does not guarantee a future return.
When was Apnimed's analyst forecast verified?
The data was verified on 2026-08-29. The dataset is valid through 2026-09-05.